Dr. Reddy’s launches Nystatin, Triamcinolone Acetonide Cream in US market

05 Dec 2016 Evaluate

Dr. Reddy’s Laboratories has launched Nystatin and Triamcinolone Acetonide Cream, USP, in the United States market, approved by the US Food & Drug Administration (USFDA). Nystatin and Triamcinolone Acetonide Cream, USP is the generic equivalent of Nystatin and Triamcinolone Acetonide Cream, USP 100,000 units/g-0.1% manufactured by Taro Pharmaceuticals USA Inc.

The generic had US sales of approximately $119 million MAT for the most recent twelve months ended in October 2016, according to IMS Health. Dr. Reddy’s Nystatin and Triamcinolone Acetonide Cream, USP is available in tube sizes of 15g, 30g and 60g.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1269.05 2.70 (0.21%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×